SLC6A3 and attention deficit-hyperactivity disorder: DAT also contributes to pathophysiology in both central and peripheral nervous systems, especially in central nervous system diseases, such as Parkinson's disease (PD), substance use disorders (SUDs), major depressive disorder (MDD), and attention deficit hyperactivity disorder (ADHD).